Eyewear Giant Lenskart Submits IPO Papers to SEBI for ₹8,000 Crore Listing

Eyewear retailer Lenskart has launched its plans for an ₹8,000 crore IPO by filing a draft red herring prospectus with SEBI, as per news reports. This move marks one of the largest public offerings among new-age Indian companies in 2025.
Lenskart’s IPO: Fresh Issue and OFS Breakdown
Lenskart’s IPO includes a fresh issue of shares worth ₹2,150 crore and an offer for sale (OFS) of up to 132.2 million shares. The OFS component will see investors such as SoftBank, Alpha Wave Global, Temasek, and Kedaara Capital reduce their holdings. Founders Peyush Bansal, Neha Bansal, Amit Chaudhary, and Sumeet Kapahi will together offload 31.8 million shares through the OFS.
Use of Proceeds: Retail Expansion and Tech Investment
₹272 crore from the fresh issue will be used for opening new stores in India, while ₹591 crore is allocated for expenses related to leasing and management of existing outlets. Additional funds will support global expansion, supply chain optimisation, and technology upgrades.
Lenskart FY25 Financial Overview
Lenskart became profitable in FY25, reporting a net profit of ₹297 crore compared to a net loss of ₹10 crore in FY24. The revenue grew by 22% year-on-year, reaching ₹6,625 crore. In contrast, Titan EyeCare posted FY25 revenue of ₹796 crore, a 10% jump from the previous year.
Read More: Lenskart Strong FY25: $755 Million Revenue, Over $200 Million Cash Ahead of IPO!
Global Reach and Growth from OwnDays Acquisition
Over 40% of Lenskart’s FY25 revenue came from international markets like Taiwan, Japan, and the Middle East. This global push is largely attributed to its acquisition of Japanese eyewear brand OwnDays in 2022. The standalone international revenue stood at ₹2,638 crore, a 17% rise over the previous year.
Conclusion
Lenskart’s proposed ₹8,000 crore IPO reflects strong growth both in India and abroad. With key investors partially exiting and the company investing in scalable assets, it positions itself for long-term market leadership in the eyewear space.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Jul 29, 2025, 3:17 PM IST

Team Angel One
- Symbiotec Pharmalab Share Price: Stock Lists at Flat on NSE
- Hy-Tech Engineers Share Price: Stock Lists at 41.51% Premium on NSE
- Skyways Air Services Share Price: Stock Lists at 10.14% Discount on NSE
- Augmont Enterprises Share Price: Stock Lists at 21.95% Premium on NSE
- Upcoming IPOs This Week (August 31–September 4, 2026): Purple Style Labs, Deepa Jewellers and Others


